-
Something wrong with this record ?
Heart Rate and Heart Rate Variability Changes Are Not Related to Future Cardiovascular Disease and Death in People With and Without Dysglycemia: A Downfall of Risk Markers? The Whitehall II Cohort Study
CS. Hansen, ME. Jørgensen, M. Malik, DR. Witte, EJ. Brunner, AG. Tabák, M. Kivimäki, D. Vistisen
Language English Country United States
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Grant support
R01 HL036310
NHLBI NIH HHS - United States
RG/16/11/32334
British Heart Foundation - United Kingdom
MR/S011676/1
Medical Research Council - United Kingdom
R01 AG013196
NIA NIH HHS - United States
R01 AG056477
NIA NIH HHS - United States
RG/13/2/30098
British Heart Foundation - United Kingdom
MR/R024227/1
Medical Research Council - United Kingdom
K013351
Medical Research Council - United Kingdom
NH/16/2/32499
British Heart Foundation - United Kingdom
NLK
Free Medical Journals
from 1978
Open Access Digital Library
from 1978-01-01 to 6 months ago
Open Access Digital Library
from 2000-01-01 to 6 months ago
Medline Complete (EBSCOhost)
from 1978-01-01
PubMed
33526428
DOI
10.2337/dc20-2490
Knihovny.cz E-resources
- MeSH
- Diabetes Mellitus * MeSH
- Cardiovascular Diseases * MeSH
- Cohort Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Prospective Studies MeSH
- Risk Factors MeSH
- Heart Rate MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
OBJECTIVE: Higher resting heart rate (rHR) and lower heart rate variability (HRV) are associated with increased risk of cardiovascular disease (CVD) and all-cause mortality in people with and without diabetes. It is unknown whether temporal changes in rHR and HRV may contribute to this risk. We investigated associations between 5-year changes in rHR and HRV and risk of future CVD and death, taking into account participants' baseline glycemic state. RESEARCH DESIGN AND METHODS: In this prospective, population-based cohort study we investigated 4,611 CVD-free civil servants (mean [SD] age, 60 [5.9] years; 70% men). We measured rHR and/or six indices of HRV. Associations of 5-year change in 5-min rHR and HRV with fatal and nonfatal CVD and all-cause mortality or the composite of the two were assessed, with adjustments made for relevant confounders. Effect modification by glycemic state was tested. RESULTS: At baseline, 63% of participants were normoglycemic, 29% had prediabetes, and 8% had diabetes. During a median (interquartile range) follow-up of 11.9 (11.4; 12.3) years, 298 participants (6.5%) experienced a CVD event and 279 (6.1%) died of non-CVD-related causes. We found no association between 5-year changes in rHR and HRV and future events. Only baseline rHR was associated with all-cause mortality. A 10 bpm-higher baseline HR level was associated with an 11.4% higher rate of all-cause mortality (95% CI 1.0-22.9%; P = 0.032). Glycemic state did not modify associations. CONCLUSIONS: Changes in rHR and HRV and possibly also baseline values of these measures are not associated with future CVD or death in people with or without dysglycemia.
Danish Diabetes Academy Odense Denmark
Department of Epidemiology and Public Health University College London London U K
Department of Public Health Aarhus University Aarhus Denmark
Department of Public Health Semmelweis University Faculty of Medicine Budapest Hungary
National Heart and Lung Institute Imperial College London U K
National Institute of Public Health Southern Denmark University Odense Denmark
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21025890
- 003
- CZ-PrNML
- 005
- 20211026133415.0
- 007
- ta
- 008
- 211013s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2337/dc20-2490 $2 doi
- 035 __
- $a (PubMed)33526428
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Hansen, Christian S $u Steno Diabetes Center Copenhagen, Gentofte, Denmark chan0583@regionh.dk $u National Institute of Public Health, Southern Denmark University, Odense, Denmark
- 245 10
- $a Heart Rate and Heart Rate Variability Changes Are Not Related to Future Cardiovascular Disease and Death in People With and Without Dysglycemia: A Downfall of Risk Markers? The Whitehall II Cohort Study / $c CS. Hansen, ME. Jørgensen, M. Malik, DR. Witte, EJ. Brunner, AG. Tabák, M. Kivimäki, D. Vistisen
- 520 9_
- $a OBJECTIVE: Higher resting heart rate (rHR) and lower heart rate variability (HRV) are associated with increased risk of cardiovascular disease (CVD) and all-cause mortality in people with and without diabetes. It is unknown whether temporal changes in rHR and HRV may contribute to this risk. We investigated associations between 5-year changes in rHR and HRV and risk of future CVD and death, taking into account participants' baseline glycemic state. RESEARCH DESIGN AND METHODS: In this prospective, population-based cohort study we investigated 4,611 CVD-free civil servants (mean [SD] age, 60 [5.9] years; 70% men). We measured rHR and/or six indices of HRV. Associations of 5-year change in 5-min rHR and HRV with fatal and nonfatal CVD and all-cause mortality or the composite of the two were assessed, with adjustments made for relevant confounders. Effect modification by glycemic state was tested. RESULTS: At baseline, 63% of participants were normoglycemic, 29% had prediabetes, and 8% had diabetes. During a median (interquartile range) follow-up of 11.9 (11.4; 12.3) years, 298 participants (6.5%) experienced a CVD event and 279 (6.1%) died of non-CVD-related causes. We found no association between 5-year changes in rHR and HRV and future events. Only baseline rHR was associated with all-cause mortality. A 10 bpm-higher baseline HR level was associated with an 11.4% higher rate of all-cause mortality (95% CI 1.0-22.9%; P = 0.032). Glycemic state did not modify associations. CONCLUSIONS: Changes in rHR and HRV and possibly also baseline values of these measures are not associated with future CVD or death in people with or without dysglycemia.
- 650 12
- $a kardiovaskulární nemoci $7 D002318
- 650 _2
- $a kohortové studie $7 D015331
- 650 12
- $a diabetes mellitus $7 D003920
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdeční frekvence $7 D006339
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a rizikové faktory $7 D012307
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jørgensen, Marit E $u Steno Diabetes Center Copenhagen, Gentofte, Denmark
- 700 1_
- $a Malik, Marek $u National Heart and Lung Institute, Imperial College, London, U.K $u Department of Internal Medicine and Cardiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Witte, Daniel R $u National Institute of Public Health, Southern Denmark University, Odense, Denmark $u Department of Public Health, Aarhus University, Aarhus, Denmark $u Danish Diabetes Academy, Odense, Denmark $u Steno Diabetes Center Aarhus, Aarhus, Denmark
- 700 1_
- $a Brunner, Eric J $u Department of Epidemiology and Public Health, University College London, London, U.K
- 700 1_
- $a Tabák, Adam G $u Department of Epidemiology and Public Health, University College London, London, U.K $u Department of Internal Medicine and Oncology, Semmelweis University Faculty of Medicine, Budapest, Hungary $u Department of Public Health, Semmelweis University Faculty of Medicine, Budapest, Hungary
- 700 1_
- $a Kivimäki, Mika $u Department of Epidemiology and Public Health, University College London, London, U.K
- 700 1_
- $a Vistisen, Dorte $u Steno Diabetes Center Copenhagen, Gentofte, Denmark
- 773 0_
- $w MED00001380 $t Diabetes care $x 1935-5548 $g Roč. 44, č. 4 (2021), s. 1012-1019
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33526428 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133421 $b ABA008
- 999 __
- $a ok $b bmc $g 1714793 $s 1146397
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 44 $c 4 $d 1012-1019 $e 20210201 $i 1935-5548 $m Diabetes care $n Diabetes Care $x MED00001380
- GRA __
- $a R01 HL036310 $p NHLBI NIH HHS $2 United States
- GRA __
- $a RG/16/11/32334 $p British Heart Foundation $2 United Kingdom
- GRA __
- $a MR/S011676/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a R01 AG013196 $p NIA NIH HHS $2 United States
- GRA __
- $a R01 AG056477 $p NIA NIH HHS $2 United States
- GRA __
- $a RG/13/2/30098 $p British Heart Foundation $2 United Kingdom
- GRA __
- $a MR/R024227/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a K013351 $p Medical Research Council $2 United Kingdom
- GRA __
- $a NH/16/2/32499 $p British Heart Foundation $2 United Kingdom
- LZP __
- $a Pubmed-20211013